Zika Update: Findings from the U.S. Zika Pregnancy Registry and Updated Clinical Guidance
CDC recently released its latest findings from the U.S. Zika Pregnancy Registry (USZPR) on Zika virus infection in pregnant women and infants, which highlight the importance of prevention and early care. Additionally, CDC has released additional considerations for evaluating and managing infants with possible congenital Zika virus infection. Zika virus infection during pregnancy is a cause of microcephaly and other serious brain defects; however, the full range of potential health problems that Zika virus infection during pregnancy may cause is not yet known. Healthcare providers need information to appropriately evaluate and manage patients with possible Zika virus infection. During this COCA Call, clinicians will learn about the latest findings from the USZPR and updated CDC clinical guidance to assist in caring for these patients based on currently available data.
Sonja Rasmussen, MD, MS
Director, Division of Public Health Information Dissemination
Editor-in-Chief, Morbidity and Mortality Weekly Report
Center for Surveillance, Epidemiology, and Laboratory Services
Centers for Disease Control and Prevention
Emily Petersen, MD
Division of Reproductive Health
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention
At the conclusion of the session, the participant will be able to accomplish the following:
- Understand the latest estimates for birth defects associated with Zika virus infection during pregnancy.
- Discuss additional considerations for evaluating and managing infants with possible congenital Zika virus infection.
- Apply the updated recommendations outlined in the additional considerations for the evaluation and management of infants with possible congenital Zika virus infection.
- Slides: View Nowpdf icon
- Webinar: Watch Nowmedia icon
- Transcript: Read Now
- Audio conference call on Thursday, 05/04/17: 2:00 - 3:00 PM (Eastern Time)
- Web-on-demand training after 3:00 PM on 05/04/17
- Materials: PowerPoint slide set
“WC2286” for attendees who participate in the live call (must be completed by June 4, 2017)
“WD2286” for attendees who participate in the online presentation (must be completed by June 4, 2019)
- Physician Assistants
- Health Educators
- Other Clinicians
- Contact Information:email@example.com
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communications Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.
- Fees:COCA continuing education credits are free.
CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity provides 1.0 contact hour.
IACET CEU:The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU's for this program.
CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-17-156-L04-P and enduring 0387-0000-17-156-H04-P course category.Course Category: This activity has been designated as knowledge-based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at firstname.lastname@example.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.
CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.orgexternal icon.
There is no cost for this program.
DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
CDC does not accept commercial support.